I know the company is in great hands with Richard at the helm and look forward to continuing to support the entire BioIVT team going forward,' said Mr. I am so proud of the growth we have achieved and the positive impact we have been able to make to the healthcare and life science industries in such an important and dynamic way. 'Serving as CEO of BioIVT for the past 26 years has been a privilege and incredible experience. Gatz has successfully led and grown the business from a small family operation to a global enterprise employing over 500 people and serving thousands of pharma, biotech, CRO and diagnostic customers worldwide. Haigh.įormer CEO Jeff Gatz who is retiring from day-to-day involvement with BioIVT will continue to support the company as an advisor focused on M&A and business development activities. We have a tremendous runway ahead of us with multiple avenues for continued growth, and I am excited by the opportunity to contribute to this organization,' said incoming CEO Dr. BioIVT is a fantastic mission driven business focused on enabling our customers to more efficiently and effectively develop new therapeutics that save lives. 'I am delighted and honored to be taking on the CEO role at BioIVT during this exciting time. Haigh joined BioIVT in May 2022 as Chief Operating Officer and brings over 27 years' experience in the life science research and diagnostics space covering products, consumables, and services, including over 15 years with Thermo Fisher Scientific/Life Technologies.

1, 2022 /PRNewswire/ - BioIVT, LLC ('BioIVT'), a leading global provider of biospecimens, cell and gene therapy related products, and research models and services for drug development purposes, today announced the promotion of Richard Haigh, PhD, to Chief Executive Officer (CEO) effective August 1.

The Farm by Richard Haigh